[
  {
    "ts": null,
    "headline": "Bringing Advanced Vascular Diagnostics to the Western US with the SmartVascular Dx™ Test",
    "summary": "IRVINE, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC., (“MSL” or “the Company”), a leading developer of precision diagnostic tests addressing unmet clinical needs, is excited to announce that its SmartVascular Dx™ (SVDx) test, formerly known as the PULS™ Cardiac Test, is now available in the Western United States. This innovative diagnostic tool aims to enhance vascular health monitoring in the region. We are pleased to share that the SmartVascular Dx test has been inc",
    "url": "https://finnhub.io/api/news?id=3e095bc3c654ab1ca75efc0aa77807be4f49537d9bdba1b48693181bc0b7f07f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754679240,
      "headline": "Bringing Advanced Vascular Diagnostics to the Western US with the SmartVascular Dx™ Test",
      "id": 136276808,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MOH",
      "source": "Yahoo",
      "summary": "IRVINE, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC., (“MSL” or “the Company”), a leading developer of precision diagnostic tests addressing unmet clinical needs, is excited to announce that its SmartVascular Dx™ (SVDx) test, formerly known as the PULS™ Cardiac Test, is now available in the Western United States. This innovative diagnostic tool aims to enhance vascular health monitoring in the region. We are pleased to share that the SmartVascular Dx test has been inc",
      "url": "https://finnhub.io/api/news?id=3e095bc3c654ab1ca75efc0aa77807be4f49537d9bdba1b48693181bc0b7f07f"
    }
  },
  {
    "ts": null,
    "headline": "U.S. Health Insurers See Costs Mount, Income Estimates Decline In Q2",
    "summary": "Many of the largest publicly traded US health insurers had a difficult second quarter as rising costs associated with government-subsidized health plans exacerbated ongoing declines in EPS.",
    "url": "https://finnhub.io/api/news?id=465563402fabdca904849453a77e383db2b22b84a3fdc04ee6fab775bfbf5f65",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754623500,
      "headline": "U.S. Health Insurers See Costs Mount, Income Estimates Decline In Q2",
      "id": 136264838,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1094776474/image_1094776474.jpg?io=getty-c-w1536",
      "related": "MOH",
      "source": "SeekingAlpha",
      "summary": "Many of the largest publicly traded US health insurers had a difficult second quarter as rising costs associated with government-subsidized health plans exacerbated ongoing declines in EPS.",
      "url": "https://finnhub.io/api/news?id=465563402fabdca904849453a77e383db2b22b84a3fdc04ee6fab775bfbf5f65"
    }
  }
]